{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:26:33Z","timestamp":1790717193464,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Gastroesophageal reflux disease (GERD) is a prevalent global condition, affecting 18.1\u201327.8% of North Americans and 6.3\u201318.3% of the Thai population. While proton pump inhibitors (PPIs) are the first-line treatment, only about one-third of patients achieve adequate symptom control. Alginate-based medications in combination with PPIs have shown promise, but the comparative effectiveness of generic versus original alginates remains unexplored. To compare the effectiveness of generic alginate (ONE GERD) versus original alginate (Gaviscon Dual Action Suspension) in combination with PPIs for treating GERD symptoms in patients who failed standard PPI therapy.This multicenter prospective randomized controlled non-inferiority trial included 48 patients who failed standard-dose PPI treatment. Patients were randomized to receive either generic or original alginate four times daily for 28\u00a0days. Treatment response was evaluated using the Reflux Disease Questionnaire (RDQ) at days 7 and 28. At day 7, both groups showed identical response rates of 45.83%. By day 28, response rates increased to 54.17% for generic alginate and 70.83% for original alginate (<jats:italic>p<\/jats:italic>\u2009=\u20090.23). Total RDQ scores and symptom-free rates showed no significant differences between groups at both time points. Adverse event rates were comparable (16.67% vs. 8.33%, <jats:italic>p<\/jats:italic>\u2009=\u20090.66). Analysis of specific symptoms (heartburn, chest pain, and regurgitation) revealed similar improvements in both groups throughout the study period. This study provides evidence supporting the therapeutic equivalence of the generic alginate (ONE GERD) to the original formulation (Gaviscon Dual Action Suspension) in treating symptoms for patients with GERD who have failed PPI therapy. Crucially, the comparable efficacy and safety, coupled with the inherent lower cost of generic medications, suggest significant economic benefits and the potential for wider patient access to effective GERD management.  This makes generic alginate a viable and attractive alternative in clinical practice, particularly in resource-limited settings or for patients facing financial constraints, thereby contributing to more equitable healthcare solutions without compromising therapeutic outcomes. <\/jats:p>","DOI":"10.1038\/s41598-025-13400-w","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:48:44Z","timestamp":1754326124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparable efficacy of generic and original alginate for symptom control in PPI-refractory GERD"],"prefix":"10.1038","volume":"15","author":[{"given":"Kawin","family":"Tangvoraphonkchai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witsarut","family":"Manasirisuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Apichatvullop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supatra","family":"Srikhajonjit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoon","family":"Mitpracha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattarakorn","family":"Promsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nutchanun","family":"Preechakawin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaimook","family":"Onthaisong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"4","key":"13400_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5056\/jnm18140","volume":"24","author":"T Yamasaki","year":"2018","unstructured":"Yamasaki, T., Hemond, C., Eisa, M., Ganocy, S. & Fass, R. The changing epidemiology of gastroesophageal reflux disease: Are patients getting younger?. J. Neurogastroenterol. Motil. 24(4), 559\u2013569 (2018).","journal-title":"J. Neurogastroenterol. Motil."},{"issue":"4","key":"13400_CR2","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/jgh.15758","volume":"37","author":"M Maneerattanaporn","year":"2022","unstructured":"Maneerattanaporn, M. et al. Thailand guideline 2020 for medical management of gastroesophageal reflux disease. J. Gastroenterol. Hepatol. 37(4), 632\u2013643 (2022).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"13400_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5056\/jnm.2011.17.1.14","volume":"17","author":"HK Jung","year":"2011","unstructured":"Jung, H. K. Epidemiology of gastroesophageal reflux disease in Asia: A systematic review. J. Neurogastroenterol. Motil. 17(1), 14\u201327 (2011).","journal-title":"J. Neurogastroenterol. Motil."},{"issue":"3","key":"13400_CR4","first-page":"293","volume":"57","author":"S Treeprasertsuk","year":"2013","unstructured":"Treeprasertsuk, S., Thongbai, T., Rattanachuek, T. & Mahachai, V. Prevalence of GERD in a community-based examination in Thailand. Chula. Med. J. 57(3), 293\u2013303 (2013).","journal-title":"Chula. Med. J."},{"issue":"5","key":"13400_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1442-2050.2011.01276.x","volume":"25","author":"N Manabe","year":"2012","unstructured":"Manabe, N. et al. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: A randomized clinical trial. Dis. Esophagus 25(5), 373\u2013380 (2012).","journal-title":"Dis. Esophagus"},{"issue":"2","key":"13400_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000080308","volume":"22","author":"I Wiklund","year":"2004","unstructured":"Wiklund, I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig. Dis. 22(2), 108\u2013114 (2004).","journal-title":"Dig. Dis."},{"issue":"3","key":"13400_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000336072","volume":"85","author":"K Tsuboi","year":"2012","unstructured":"Tsuboi, K. et al. Insights gained from symptom evaluation of esophageal motility disorders: A review of 4215 patients. Digestion 85(3), 236\u2013242 (2012).","journal-title":"Digestion"},{"issue":"1","key":"13400_CR8","first-page":"71","volume":"40","author":"K Santayakorn","year":"2021","unstructured":"Santayakorn, K. & Tanprasert, S. Prevalence and factors associated with laryngopharyngeal reflux (LPR) among patients diagnosed with GERD in Samphran hospital Nakhon Pathom. Reg. 4\u20135 Med. J. 40(1), 71\u201380 (2021).","journal-title":"Reg. 4\u20135 Med. J."},{"issue":"1","key":"13400_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1572-0241.2001.03451.x","volume":"96","author":"MJ Shaw","year":"2001","unstructured":"Shaw, M. J. et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am. J. Gastroenterol. 96(1), 52\u201357 (2001).","journal-title":"Am. J. Gastroenterol."},{"issue":"3\u20134","key":"13400_CR10","first-page":"162","volume":"74","author":"MC Aanen","year":"2007","unstructured":"Aanen, M. C., Numans, M. E., Weusten, B. L. A. M. & Smout, A. J. P. M. Diagnostic value of the reflux disease questionnaire in general practice. Digestion 74(3\u20134), 162\u2013168 (2007).","journal-title":"Digestion"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13400-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13400-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13400-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:59:31Z","timestamp":1757339971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13400-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13400"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13400-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28429"}}